References
- Belhassen M, Nibber A, Van Ganse E, Ryan D, Langlois C, Appiagyei F, Skinner D, Laforest L, Soriano JB, Price D, et al. Inappropriate asthma therapy—a tale of two countries: a parallel population-based cohort study. NPJ Prim Care Resp Med. 2016;26(1):16076. doi:https://doi.org/10.1038/npjpcrm.2016.76.
- Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2019. Available from: www.ginasthma.org
- National Asthma Council (NAC). Asthma management handbook. National Asthma Council Australia Melbourne; 2018.
- Gerald JK, Carr TF, Wei CY, Holbrook JT, Gerald LB. Albuterol overuse: a marker of psychological distress? J Allergy Clin Immunol Pract. 2015;3(6):957–962. doi:https://doi.org/10.1016/j.jaip.2015.06.021.
- Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin S-L, Globe G, Sullivan PW. Asthma control in the United States, 2008-2010: indicators of poor asthma control. J Allergy Clin Immunol. 2014;133(6):1579–1587. doi:https://doi.org/10.1016/j.jaci.2013.10.028.
- McHorney CA, Gadkari AS. Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Prefer Adherence. 2010;4:187–195. doi:https://doi.org/10.2147/ppa.s10603.
- Axelsson M, Emilsson M, Brink E, Lundgren J, Torén K, Lötvall J. Personality, adherence, asthma control and health-related quality of life in young adult asthmatics. Respir Med. 2009;103(7):1033–1040. doi:https://doi.org/10.1016/j.rmed.2009.01.013.
- Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med. 1997;45(2):189–201.
- Azzi EA, Kritikos V, Peters MJ, Price DB, Srour P, Cvetkovski B, Bosnic-Anticevich S. Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey. BMJ Open. 2019;9(8):e028995.
- Casset A, Meunier-Spitz M, Rebotier P, Lefèvre H, Barth C, Heitz C, de Blay F. Asthma management and inhalation techniques among community pharmacists in 2009: a comparison with the 1999 survey. J Asthma. 2014;51(9):964–973.
- Paris J, Peterson EL, Wells K, Pladevall M, Burchard EG, Choudhry S, Lanfear DE, Williams LK. Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol. 2008;101(5):482–487.
- Bhagat R, Swystun VA, Cockcroft DW. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J Allergy Clin Immunol. 1996;97(1):47–52.
- Lundblad LKA, Rinaldi LM, Poynter ME, Riesenfeld EP, Wu M, Aimi S, Barone LM, Bates JHT, Irvin CG. Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma. Respir Res. 2011;12(1):27. doi:https://doi.org/10.1186/1465-9921-12-27.
- Wraight JM, Smith AD, Cowan JO, Flannery EM, Herbison GP, Taylor DR. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate. Respirology. 2004;9(2):215–221. doi:https://doi.org/10.1111/j.1440-1843.2004.00557.x.
- Sears MR. Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ. Chest. 2001;119(5):1297–1299. doi:https://doi.org/10.1378/chest.119.5.1297.
- Bosnic-Anticevich S, Kritikos V, Carter V, Yan KY, Armour C, Ryan D, Price D. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia. J Asthma. 2018;55(6):684–694. doi:https://doi.org/10.1080/02770903.2017.1353611.
- Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Paré P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ. 2001;164(5):625–631.
- Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009. doi:https://doi.org/10.1038/npjpcrm.2014.9.
- Reddel HK, Sawyer SM, Everett PW, Flood PV, Peters MJ. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015;202(9):492–497. doi:https://doi.org/10.5694/mja14.01564.
- Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, Humbert M, Jones P, Gibson PG, Vestbo J, et al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016;47(2):410–419. doi:https://doi.org/10.1183/13993003.01359-2015.
- David-Wang A, Price D, Cho SH, Ho JCM, Liam CK, Neira G, Teh PL, REcognise Asthma and LInk to Symptoms and Experience (REALISE) Asia Working Group. Development and validation of an attitudinal-profiling tool for patients with asthma. Allergy Asthma Immunol Res. 2017;9(1):43–51. doi:https://doi.org/10.4168/aair.2017.9.1.43.
- Australian Bureau of Statistics (ABS). National health survey: first results 2014-15. Canberra: ABS; 2015.
- Price D, David-Wang A, Cho S-H, Ho JC-M, Jeong J-W, Liam C-K, Lin J, Muttalif AR, Perng D-W, Tan T-L, et al. Time for a new language for asthma control: results from REALISE Asia. J Asthma Allergy. 2015;8:93–103. doi:https://doi.org/10.2147/JAA.S82633.
- Partridge MR, van der Molen T, Myrseth S-E, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. doi:https://doi.org/10.1186/1471-2466-6-13.
- Fletcher M, Hiles D. Continuing discrepancy between patient perception of asthma control and real-world symptoms: a quantitative online survey of 1,083 adults with asthma from the UK. Prim Care Respir J. 2013;22(4):431–438. doi:https://doi.org/10.4104/pcrj.2013.00091.
- Horne R, Weinman J. Self-regulation and self-management in Asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17(1):17–32.
- Horne R, Chapman SCE, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework. PLoS One. 2013;8(12):e80633.
- Armour CL, Reddel HK, LeMay KS, Saini B, Smith LD, Bosnic-Anticevich SZ, Song YJC, Alles MC, Burton DL, Emmerton L, et al. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma. 2013;50(3):302–309. doi:https://doi.org/10.3109/02770903.2012.754463.
- Wamboldt FS, Bender BG, Rankin AE. Adolescent decision-making about use of inhaled asthma controller medication: results from focus groups with participants from a prior longitudinal study. J Asthma. 2011;48(7):741–750. doi:https://doi.org/10.3109/02770903.2011.598204.
- Lycett H, Wildman E, Raebel EM, Sherlock J-P, Kenny T, Chan AHY. Treatment perceptions in patients with asthma: synthesis of factors influencing adherence. Respir Med. 2018;141:180–189. doi:https://doi.org/10.1016/j.rmed.2018.06.032.
- Chiu K-C, Boonsawat W, Cho S-H, Cho YJ, Hsu J-Y, Liam C-K, Muttalif AR, Nguyen HD, Nguyen VN, Wang C, et al. Patients' beliefs and behaviors related to treatment adherence in patients with asthma requiring maintenance treatment in Asia. J Asthma. 2014;51(6):652–659.
- Foster JM, Smith L, Bosnic-Anticevich SZ, Usherwood T, Sawyer SM, Rand CS, Reddel HK. Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma. Intern Med J. 2012;42(6):e136-44.